We have produced an unique online pathway to empower people at risk of severe allergies to get the correct diagnosis and care to prevent anaphylaxis.
Access the pathway here – http://aimallergy.co.uk/
Currently one in three of the UK population, or 21 million people (4), live with an allergy of some form and this number is increasing at an alarming rate. Hospital admissions in England for allergy and anaphylaxis have risen by more than a third in the last five years (3). Up to 7 million have an allergy severe enough to require specialist allergy care (5).
Anaphylaxis is a terrifying severe allergic reaction that can be fatal, but severe allergies can be safely managed once correctly diagnosed by a medical professional.
Lynne Regent, CEO, Anaphylaxis Campaign said: “Our easy to use pathway is for anyone who thinks they or their child has an allergy – so they can find out if they could be at risk and if so make an appointment to see their doctor. The information provided in the pathway is based on the recent National Institute for Health and Care Excellence (NICE) Guidelines for the diagnosis and assessment of food allergy in children and young people in primary care and community settings. The information is relevant for children and adults.”
This pathway is vital to save lives as Katie’s story demonstrates; “After I joined the Anaphylaxis Campaign last year as a member, I decided to push my Doctor to give me an adrenaline auto-injector for my baby boy who had been diagnosed with a nut allergy and given antihistamines to manage it. It was only after reading the information that the Anaphylaxis Campaign sent to me about adrenaline being the proper treatment for this rather than antihistamines that I wrote to my Doctor and insisted on another appointment. The doctor then prescribed two adrenaline auto-injectors. Thank goodness I did because shortly afterwards he had a very violent anaphylactic reaction to coconut. I had to administer one injector and the paramedics gave more adrenaline when they arrived.”
The Anaphylaxis Campaign’s ‘Anaphylaxis Information Matters (AIM)’ campaign has additional materials to assist patients and healthcare professionals including a patient information leaflet, a poster for GP surgeries and a short guideline to the NICE Quality Standards. All can be accessed on the Anaphylaxis Campaign’s website.
All the AIM materials, including the pathway, have been clinically reviewed by members of the Anaphylaxis Campaign’s Clinical and Scientific Panel (2).
Funding for the AIM campaign was kindly provided by the Durant and Lineham families who both lost daughters to anaphylaxis in recent years. Both girls were tragically unaware how severe their allergy could be and had not been prescribed adrenaline auto-injectors
- Anaphylaxis Campaign is the only UK wide charity operating solely for the growing numbers of people at risk from severe allergic reactions and anaphylaxis. Find out more about us and find out how to support our work through membership, fundraising and donations on our website – www.anaphylaxis.org.uk. We receive no government funding or grants so we rely on your support to continue our work.
- The AIM materials have been clinically reviewed by – Dr Liz Angier, Portfolio GP, Q Member Health Foundation, Clinical Fellow National Leadership Academy; Dr Trevor Brown, Consultant Paediatric Allergist, and Vice Chair of Anaphylaxis Campaign’s Clinical Panel; Dr Andrew Clark, Consultant in Paediatric Allergy and Chair of the Anaphylaxis Campaign’s Clinical Panel and Dr Joanne Walsh, GP, Chair of Primary care group BSACI.
- Data from NHS Digital shows there were 29,544 hospital admissions in 2015-16 for allergic reactions. That compares to 22,206 admissions in 2011-12.
- Mintel, 2010
- BSACI, Newsletter: Allergy Update, 2011, issue 17 http://www.bsaci.org/publications/AU17_spring2011.pdf